체중증가 발생 가능성에 따른 항정신병약물 네 군 간의 정신분열병 환자의 주관적 삶의 질 비교 연구
Comparison of the Subjective Quality of Life in Four Groups of Antipsychotics by Risk of Weight Gain in Patients with Schizophrenia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives The aim of this cross-sectional study was to compare the subjective quality of life in the four groups of antipsychotics according to the risk of weight gain in patients with schizophrenia. Methods One hundred and thirty-two patients with schizophrenia that had taken the same antipsychotics for more than 1 year were enrolled in the analyses. Anti-psychotic agents were classified by the risk of weight gain into four groups : serious, common, not unusual, and unusual. The quality of life was measured with the Schizophrenia Quality of Life Scale Korean version, 4th Revision (SQLS-R4K). We analyzed the correlation between the total score of SQLS-R4K and clinical variables. Results The SQLS-R4K score was significantly different in the four anti-psychotic groups (F=5.200, p=0.002). Gender, type of anti-psychotics (typical, atypical), duration of treatment with current antipsychotics, duration of illness, and Body Mass Index were not significantly correlated with the SQ-LS-R4K score. Conclusion The subjective quality of life was different according to the risk of weight gain groups of anti-psychotic agents.
Abstract
Objectives The aim of this cross-sectional study was to compare the subjective quality of life in the four groups of antipsychotics according to the risk of weight gain in patients with schizophrenia. Methods One hundred and thirty-two patients with schizophrenia that had taken the same antipsychotics for more than 1 year were enrolled in the analyses. Anti-psychotic agents were classified by the risk of weight gain into four groups : serious, common, not unusual, and unusual. The quality of life was measured with the Schizophrenia Quality of Life Scale Korean version, 4th Revision (SQLS-R4K). We analyzed the correlation between the total score of SQLS-R4K and clinical variables. Results The SQLS-R4K score was significantly different in the four anti-psychotic groups (F=5.200, p=0.002). Gender, type of anti-psychotics (typical, atypical), duration of treatment with current antipsychotics, duration of illness, and Body Mass Index were not significantly correlated with the SQ-LS-R4K score. Conclusion The subjective quality of life was different according to the risk of weight gain groups of anti-psychotic agents.
참고문헌 (30)
- Bigelow DA, "The concept and measurement of quality of life as dependent variable in evaluation of mental health services. In Innovative Approach to Mental Health Evaluation", pp.345~366 (1982), NewYork: Academic Press
- Choi YH, "Overview of quality of life in psychiatry", J Korean Neuropsychiatr Assoc, 36, pp.19~31 (1997)
- Bow-Thomas CC, "Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization", Psychiatry Res, 86, pp.131~142 (1999)
- Huppert JD, "Quality of life in schizophrenia: contributions of anxiety and depression", Schizophr Res, 51, pp.171~180 (2001)
- Becker M, "A new patient focused index for measuring quality of life in persons with severe and persistent mental illness", Qual Life Res, 2, pp.239~251 (1993)
- 김종훈, "비정형 항정신병약물을 투여 중인 정신분열병 환자의 주관적 삶의 질 : 정신병리, 약물 부작용 및 약물에 대한 주관적 반응과의 관련성", 신경정신의학, 42(2) (2003), 대한신경정신의학회
- Lindström LH, "Long-term clinical and social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs", Acta Psychiatr Scand Suppl, 380, pp.74~76 (1994)
- Gerlach J, "Subjective experience and mental side-effects of antipsychotic treatment", Acta Psychiatr Scand Suppl, 395, pp.113~117 (1999)
- 김용식, "비정형 항정신병제의 임상", pp.28~34 (2004), 서울대학교 출판부
- Voruganti L, "Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life", Schizophr Res, 43, pp.135~145 (2000)
- Franz M, "Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients", Br J Psychiatry, 170, pp.422~425 (1997)
- 민성길, "안정화된 만성 정신분열병 환자에서 주관적 삶의 질에 미치는 Haloperidol과 Risperidone의 영향", 신경정신의학, 41(1) (2002), 대한신경정신의학회
- Jones PB, "Randomized controlled trial of the effect on Quality of Life of secondvs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)", Arch Gen Psychiatry, 63, pp.1079~1087 (2006)
- Kolotkin RL, "Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care", Eur Psychiatry, 23, pp.561~566 (2008)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders. 4th ed. Text revision" (2000), Washington DC: American psychiatric association
- Kang SH, "Crosssectional prevalence of metabolic syndrome in Korean patients with schizophrenia", Schizophr Res, 128, pp.179~181 (2011)
- Stahl SM, "Essential psychopharmacology: The prescriber’s guide, revised and updated edition" (2006), New York: Cambridge University Press
- Wilkinson G, "Self-report quality of life measure for people with schizophrenia: the SQLS", Br J Psychiatry, 177, pp.42~46 (2000)
- Oxford Outcomes Ltd, "The Revised Schizophrenia Quality of Life Questionnaire (SQLS-R4): Users manual for the SQLS-R4" (2004), Cassington Oxford: Oxford Outcomes
- Ahn YM, "Review of protocol. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with long acting risperidone microspheres" (2005), Seoul, Korea
- 김진훈, "한국어판 정신분열병 삶의 질 척도의 개발과 PANSS와의 관련성", 신경정신의학, 45(5), pp.401~410 (2006), 대한신경정신의학회
- Kolotkin RL, "Quality of life and obesity", Obes Rev, 2, pp.219~229 (2001)
- Han JH, "Metabolic syndrome and quality of life (QOL) using generalised and obesity-specific QOL scales", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(5), pp.735~741 (2009), WILEY-BLACKWELL PUBLISHING
- Allison DB, "The impact of weight gain on quality of life among persons with schizophrenia", Psychiatr Serv, 54, pp.565~567 (2003)
- Strassnig M, "Body mass index and quality of life in community-dwelling patients with schizophrenia", Schizophr Res, 62, pp.73~76 (2003)
- Mortimer AM, "Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study", Int J Soc Psychiatry, 53, pp.99~107 (2007)
- Kim EK, "Effect of clozapine on the quality of life in treatment-resistant schizophrenic patients", J Korean Neuropsychiatr Assoc, 38, pp.1447~1458 (1999)
- 서호석, "정신분열병 환자의 삶의 질과 정신병리:주관 및 객관적 평가", 신경정신의학, 40(6), pp.1122~1131 (2001), 대한신경정신의학회
- Aki H, "Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia", Psychiatry Res, 158, pp.19~25 (2008)
- Yamauchi K, "Predictors of subjective and objective quality of life in outpatients with schizophrenia", Psychiatry Clin Neurosci, 62, pp.404~411 (2008)